# PRAMEF2

## Overview
PRAMEF2 is a gene that encodes the protein PRAME family member 2, which is part of the PRAME (Preferentially Expressed Antigen in Melanoma) family. This protein is categorized as a cancer-testis antigen, which is typically expressed in reproductive tissues and certain cancers but not in most normal tissues. PRAME family member 2 is implicated in various cellular processes, including the epithelial-to-mesenchymal transition (EMT) and angiogenesis, which are critical for cancer metastasis. The protein's involvement in the HIPPO/YAP signaling pathway suggests it plays a significant role in promoting the metastatic phenotype of cancer cells, particularly in breast cancer (Nin2023Biology). The gene's expression pattern and its co-expression with other cancer-testis genes underscore its potential importance in cancer biology and its promise as a target for therapeutic intervention (Almutairi2022The; Kern2021The).

## Clinical Significance
PRAMEF2, a member of the PRAME family, is implicated in cancer metastasis, particularly through its involvement in the epithelial-to-mesenchymal transition (EMT) and angiogenesis. It promotes proliferation and the metastatic phenotype in breast cancer by acting on the HIPPO/YAP pathway, suggesting a significant role in the metastatic potential of cancer cells (Nin2023Biology). The gene is part of a co-expression network with other cancer-testis (CT) genes, indicating its potential involvement in cancer-related gene expression pathways (Almutairi2022The).

Despite its recognized role in cancer, the exact molecular mechanisms by which PRAMEF2 contributes to metastasis and EMT remain underexplored, highlighting the need for further research to understand its clinical significance and potential as a therapeutic target (Nin2023Biology). The expression profile of PRAMEF2 shows it is expressed in reproductive tissues and early embryonic stages, but not in the liver or thyroid, suggesting its role is more pronounced in specific tissues (Kern2021The). Understanding the clinical implications of PRAMEF2 in cancer could lead to novel therapeutic strategies targeting its expression or function in tumor progression.


## References


[1. (Kern2021The) Chandlar H Kern, Mingyao Yang, and Wan-Sheng Liu. The prame family of cancer testis antigens is essential for germline development and gametogenesis. Biology of Reproduction, 105(2):290â€“304, April 2021. URL: http://dx.doi.org/10.1093/biolre/ioab074, doi:10.1093/biolre/ioab074. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/biolre/ioab074)

[2. (Almutairi2022The) Mikhlid H. Almutairi, Turki M. Alrubie, Bader O. Almutairi, Abdullah M. Alamri, Abdulwahed F. Alrefaei, Maha M. Arafah, Mohammad Alanazi, and Abdelhabib Semlali. The expression patterns of human cancer-testis genes are induced through epigenetic drugs in colon cancer cells. Pharmaceuticals, 15(11):1319, October 2022. URL: http://dx.doi.org/10.3390/ph15111319, doi:10.3390/ph15111319. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ph15111319)

[3. (Nin2023Biology) Dawn Sijin Nin and Lih-Wen Deng. Biology of cancer-testis antigens and their therapeutic implications in cancer. Cells, 12(6):926, March 2023. URL: http://dx.doi.org/10.3390/cells12060926, doi:10.3390/cells12060926. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12060926)